In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank’s whole genome sequencing. He discusses the challenges and innovations in genomic data analysis, highlighting Illumina’s role in advancing genetic research and precision medicine.
SGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis Progression
SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis. After adjustments, patients on SGLT2 inhibitors had a significantly reduced risk of progression to